Aoki K - Search Results

1

Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men.

Aoki K, Kato H, Terauchi Y. Aoki K, et al. Endocr J. 2007 Dec;54(6):1009-14. doi: 10.1507/endocrj.k07-018. Epub 2007 Nov 30. Endocr J. 2007. PMID: 18048991 Free article. Clinical Trial.

2

Comparative study of effectiveness of multiple-daily injections of insulin versus twice-daily injections of biphasic insulin in patients with type 2 diabetes.

Nezu U, Nakamura A, Aoki K, Kimura M, Terauchi Y. Nezu U, et al. Among authors: aoki k. Endocr J. 2009;56(2):193-200. doi: 10.1507/endocrj.k08e-189. Epub 2008 Nov 20. Endocr J. 2009. PMID: 19023161 Free article.

3

Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.

Kikuchi K, Nezu U, Shirakawa J, Sato K, Togashi Y, Kikuchi T, Aoki K, Ito Y, Kimura M, Terauchi Y. Kikuchi K, et al. Among authors: aoki k. Endocr J. 2010;57(3):259-66. doi: 10.1507/endocrj.k09e-199. Epub 2010 Jan 19. Endocr J. 2010. PMID: 20086313 Free article.

4

Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.

Aoki K, Masuda K, Miyazaki T, Togashi Y, Terauchi Y. Aoki K, et al. Endocr J. 2010;57(8):667-72. doi: 10.1507/endocrj.k10e-103. Epub 2010 Jun 1. Endocr J. 2010. PMID: 20519806 Free article. Clinical Trial.

5

Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men.

Aoki K, Miyazaki T, Nagakura J, Orime K, Togashi Y, Terauchi Y. Aoki K, et al. Endocr J. 2010;57(8):673-7. doi: 10.1507/endocrj.k10e-064. Epub 2010 Jun 1. Endocr J. 2010. PMID: 20519807 Free article. Clinical Trial.

6

Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study.

Aoki K, Muraoka T, Ito Y, Togashi Y, Terauchi Y. Aoki K, et al. Intern Med. 2010;49(12):1085-7. doi: 10.2169/internalmedicine.49.3218. Epub 2010 Jun 15. Intern Med. 2010. PMID: 20558922 Free article. Clinical Trial.

7

Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.

Aoki K, Kamiyama H, Yoshimura K, Shibuya M, Masuda K, Terauchi Y. Aoki K, et al. Acta Diabetol. 2012 Jun;49(3):225-30. doi: 10.1007/s00592-011-0322-9. Epub 2011 Sep 6. Acta Diabetol. 2012. PMID: 21898126 Clinical Trial.

8

Comparison of plasma active glucagon-like peptide-1 (GLP-1) levels assayed with or without plasma extraction in non-diabetic men.

Masuda K, Aoki K, Terauchi Y. Masuda K, et al. Among authors: aoki k. Endocr J. 2012;59(5):435-8. doi: 10.1507/endocrj.ej12-0009. Epub 2012 Feb 21. Endocr J. 2012. PMID: 22353624 Free article.

9

Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.

Aoki K, Kamiyama H, Masuda K, Togashi Y, Terauchi Y. Aoki K, et al. Endocr J. 2013;60(4):493-9. Epub 2012 Dec 18. Endocr J. 2013. PMID: 23257734 Free article. Clinical Trial.

10

Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels.

Aoki K, Kamiyama H, Masuda K, Kamiko K, Noguchi Y, Tajima K, Terauchi Y. Aoki K, et al. Endocr J. 2014;61(3):249-56. doi: 10.1507/endocrj.ej13-0399. Epub 2013 Dec 27. Endocr J. 2014. PMID: 24389993 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,427 results

Search Page

Filters